FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Cardiac Ablation Percutaneous Catheter
PMA: P020045
·
Supplement: S101
·
Decision Aug 24, 2022
Classifications
1
FEI Numbers
52
Registration Numbers
52
Basic Information
- Device Name
- Cardiac Ablation Percutaneous Catheter
- Trade Name
- Freezor TM Cardiac Cryoablation Catheter
- PMA Number
- P020045
- Supplement Number
- S101
- Device Class
- FDA Class 3
- Product Code
- LPB
- Generic Name
- Cardiac ablation percutaneous catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- August 24, 2022
- Date Received
- July 25, 2022
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Manufacturing and supplier changes to the female coaxial connector and female coaxial fitting of the Arctic Front Advance (AFA), Arctic Front Advance Pro (AFA Pro), Freezor, Freezor Xtra, and Freezor MAX cryoablation catheters.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LPB | Cardiac Ablation Percutaneous Catheter | FDA class 3 | Unknown |